SK2872000A3 - Substituted chroman derivatives - Google Patents
Substituted chroman derivatives Download PDFInfo
- Publication number
- SK2872000A3 SK2872000A3 SK287-2000A SK2872000A SK2872000A3 SK 2872000 A3 SK2872000 A3 SK 2872000A3 SK 2872000 A SK2872000 A SK 2872000A SK 2872000 A3 SK2872000 A3 SK 2872000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- compound
- formula
- cycloalkyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703378A SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
| PCT/SE1998/001604 WO1999014213A1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK2872000A3 true SK2872000A3 (en) | 2000-11-07 |
Family
ID=20408298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK287-2000A SK2872000A3 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6387899B1 (de) |
| EP (1) | EP1025096B1 (de) |
| JP (1) | JP4002392B2 (de) |
| KR (1) | KR20010024078A (de) |
| CN (1) | CN1278809A (de) |
| AR (1) | AR016651A1 (de) |
| AT (1) | ATE255099T1 (de) |
| AU (1) | AU9193398A (de) |
| BR (1) | BR9812239A (de) |
| CA (1) | CA2303926A1 (de) |
| DE (1) | DE69820103T2 (de) |
| EE (1) | EE200000144A (de) |
| HR (1) | HRP20000133A2 (de) |
| HU (1) | HUP0100276A3 (de) |
| IL (1) | IL135074A0 (de) |
| IS (1) | IS5403A (de) |
| NO (1) | NO20001403L (de) |
| PL (1) | PL339661A1 (de) |
| SE (1) | SE9703378D0 (de) |
| SK (1) | SK2872000A3 (de) |
| TR (1) | TR200000737T2 (de) |
| WO (1) | WO1999014213A1 (de) |
| ZA (1) | ZA987806B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| CA2433950A1 (en) | 2001-01-16 | 2002-07-18 | Timothy Davenport | Therapeutic chromone compounds |
| CN100384833C (zh) * | 2001-01-16 | 2008-04-30 | 阿斯特拉曾尼卡有限公司 | 治疗用苯并二氢吡喃化合物 |
| CN100509794C (zh) | 2001-01-16 | 2009-07-08 | 阿斯特拉曾尼卡有限公司 | 治疗性杂环化合物 |
| WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
| DE60231507D1 (de) * | 2001-07-20 | 2010-07-01 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| GB0124020D0 (en) * | 2001-10-05 | 2001-11-28 | Astrazeneca Ab | Chemical compounds |
| ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
| CA2583087C (en) | 2003-09-19 | 2012-07-10 | Galileo Pharmaceuticals, Inc. | Chroman derivatives |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| TWI346109B (en) * | 2004-04-30 | 2011-08-01 | Otsuka Pharma Co Ltd | 4-amino-5-cyanopyrimidine derivatives |
| KR100681453B1 (ko) * | 2005-03-22 | 2007-02-12 | 태남자동화기기 주식회사 | 권종 분류 기능을 구비한 지폐 방출기 |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| WO2008130321A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain |
| WO2008130323A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain |
| WO2008130322A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 5-heterocyclyl-chromane derivatives for the treatment of pain |
| WO2008130319A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain |
| SA08290245B1 (ar) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0470176B1 (de) * | 1989-04-27 | 1993-12-29 | The Upjohn Company | Substituierte 3-amino-chromane |
| US5420151A (en) | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| SE8904361D0 (sv) | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
| EP1019412A1 (de) | 1995-08-11 | 2000-07-19 | Smithkline Beecham Plc | Biphenyl(thio)amid- und biphenylethan(thi)on derivate,deren herstellung undderen verwendung als 5-ht1d rezeptor-antagonisten |
-
1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 CA CA002303926A patent/CA2303926A1/en not_active Abandoned
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-09 EP EP98944378A patent/EP1025096B1/de not_active Expired - Lifetime
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/en active IP Right Grant
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Application Discontinuation
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/xx unknown
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
-
2000
- 2000-03-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1278809A (zh) | 2001-01-03 |
| ATE255099T1 (de) | 2003-12-15 |
| IL135074A0 (en) | 2001-05-20 |
| NO20001403D0 (no) | 2000-03-17 |
| US6384225B1 (en) | 2002-05-07 |
| DE69820103T2 (de) | 2004-09-02 |
| DE69820103D1 (de) | 2004-01-08 |
| AR016651A1 (es) | 2001-07-25 |
| NO20001403L (no) | 2000-05-18 |
| PL339661A1 (en) | 2001-01-02 |
| JP4002392B2 (ja) | 2007-10-31 |
| SE9703378D0 (sv) | 1997-09-18 |
| TR200000737T2 (tr) | 2000-09-21 |
| BR9812239A (pt) | 2000-07-18 |
| IS5403A (is) | 2000-03-14 |
| HUP0100276A2 (hu) | 2002-05-29 |
| HUP0100276A3 (en) | 2002-08-28 |
| CA2303926A1 (en) | 1999-03-25 |
| JP2001516755A (ja) | 2001-10-02 |
| KR20010024078A (ko) | 2001-03-26 |
| EP1025096A1 (de) | 2000-08-09 |
| US6387899B1 (en) | 2002-05-14 |
| EE200000144A (et) | 2001-02-15 |
| AU9193398A (en) | 1999-04-05 |
| ZA987806B (en) | 1999-03-18 |
| HRP20000133A2 (en) | 2001-12-31 |
| EP1025096B1 (de) | 2003-11-26 |
| WO1999014213A1 (en) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK2872000A3 (en) | Substituted chroman derivatives | |
| RU2194696C2 (ru) | Производные 1,2,3,4-тетрагидронафталина, способы их получения, фармацевтическая композиция на их основе и способ лечения | |
| JP4150161B2 (ja) | 置換されたクロマン誘導体 | |
| CZ301998A3 (cs) | Substituované 1,2,3,4-tetrahydronaftalemové deriváty, jejich použití a způsob | |
| SK2852000A3 (en) | A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A H5-HT1Bì (54) ANTAGONIST OR PARTIAL AGONIST | |
| SK2832000A3 (en) | A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A H5-HT1Bì (54) ANTAGONIST OR PARTIAL AGONIST | |
| JP4020183B2 (ja) | 置換されたインダン誘導体 | |
| JPH07188207A (ja) | １−［２ｈ−１−ベンゾピラン−２−オン−８−イル］−ピペラジン誘導体 | |
| AU778674B2 (en) | New morpholinobenzamide salts | |
| SK2842000A3 (en) | A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVEì (54) H5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
| CZ2000948A3 (cs) | Substituované chromanové deriváty | |
| MXPA00002763A (en) | Substituted chroman derivatives | |
| CZ2000947A3 (cs) | Substituované chromanové deriváty | |
| CZ2000944A3 (cs) | Kombinace inhibitoru monoaminoxidázy a antagonisty nebo parciárního agonisty Ii5-HT1B | |
| MXPA00002770A (en) | Substituted chroman derivatives | |
| MXPA01007403A (en) | New morpholinobenzamide salts |